| Faith R Torres, MFTA | |
|
4500 S. 2180 E., Ste 165, Holladay, UT 84117 | |
| (801) 613-8677 | |
| Not Available |
| Full Name | Faith R Torres |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 4500 S. 2180 E., Holladay, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629345236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 7610582-3904 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Faith R Torres, MFTA 4500 S. 2180 E., Ste 165, Holladay, UT 84117 Ph: (801) 613-8677 | Faith R Torres, MFTA 4500 S. 2180 E., Ste 165, Holladay, UT 84117 Ph: (801) 613-8677 |
News Archive
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
Dicom Systems have revealed that they will be unveiling the latest addition to the DCMSYS product family at the upcoming 2010 Annual HIMSS (Healthcare Information and Management Systems Society) Conference & Exhibition. This industry-driven conference is being held at the Georgia World Congress Center in Atlanta, GA, between March 1-4.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper will be published May 15 in Cancer Research.
› Verified 2 days ago
Emily Haynes Thomas, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2290 E 4500 S Ste 215, Holladay, UT 84117 Phone: 801-718-2187 | |
Christopher Daniel Adams, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4190 S Highland Dr, Ste 200, Holladay, UT 84124 Phone: 801-272-3200 | |
Allison Hunt, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6320 S Cobblecrest Rd, Holladay, UT 84121 Phone: 408-666-5409 | |
Carolynn Redd-recksiek, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4625 S 2300 E Ste 210, Holladay, UT 84117 Phone: 801-865-1453 | |
Ms. Carly Brooke Snow, MA, AMFT, 1000-ERYT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4624 S Holladay Blvd, Holladay, UT 84117 Phone: 801-558-5950 | |
Damon Paul Bryan, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2290 E 4500 S Ste 180, Holladay, UT 84117 Phone: 970-403-2458 |